About this episode
Richard ‘Rick’ Doblin is the founder and director of Multidisciplinary Association for Psychedelic Studies (MAPS) - a non-profit research organisation established in 1986.
Somewhere between getting an undergraduate degree in psychology and a doctorate in public policy, Rick, having had discovered psychedelics, began his fight against unjustified criminalisation of psychedelic drugs.
Rick’s main goal has been making MDMA a FDA-approved medicine, tune in to this week’s episode to find out about his progress!
MAPS latest MDMA study in Nature Medicine
Drug Science live podcast recording with Professor David Nutt!
Multidisciplinary Association for Psychedelic Studies (MAPS)
Cuban Missile Crisis, Vietnam War
Programming & Metaprogramming in the Human Biocomputer: Theory & Experiments
Realms of the Human Unconscious: Observations from LSD Research by Stanislav Grof
New Genesis: Shaping a global spirituality by Robert Muller
Post-traumatic stress disorder (PTSD)
Dissociative identity disorder
★ Support this podcast ★Get every episode summarized
Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Drug Science Podcast
158. The Story of Pharmacology with Prof Rod Flower
The Drug Science Podcast
157. Psychedelics and Christianity with Wendi Rees
The Drug Science Podcast
156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda
The Drug Science Podcast
155. The History of Schizophrenia with Justin Garson
The Drug Science Podcast